Azurocidin is a multifunctional endotoxin binding serine protease homolog s
ynthesized du-ibg the promyelocytic stage of neutrophil development, To cha
racterize the biosynthesis and processing of azurocidin, cDNA encoding huma
n preproazurocidin was stably transfected to the rat basophilic leukemia ce
ll line RBL-1 and the murine myeloblast-like cell line 32D cl3; cell lines
preciously utilized to study the related proteins cathepsin G and proteinas
e 3, After 30 min of pulse radiolabeling, two forms of newly synthesized pr
oazurocidin (34.5 and 37 kDa), differing in carbohydrate content but with p
rotein cores of identical sizes, were recognized, With time, the 34.5-kDa f
orm disappeared, while the 37-kDa form was further processed proteolyticall
y, as judged by digestion with N-glycosidase F. Conversion of high-mannose
oligosaccharides into complex forms was shown by acquisition of complete re
sistance to endoglycosidase H, Radiosequence analysis demonstrated that the
amino-terminal seven amino acid propeptide of proazurocidin was removed in
a stepwise manner during processing; initial removal of five amino acids w
as followed by cleavage of a dipeptide, Presence of the protease inhibitors
Gly-Phe-diazomethyl ketone, bestatin, or leupeptin inhibited only the clea
vage of the dipeptide, thus indicating the involvement of at least two amin
o-terminal processing enzymes. Translocation of azurocidin to granules was
shown by subcellular fractionation. Similar results, with efficient biosynt
hesis, processing, and targeting to granules in both cell lines, were obtai
ned with a mutant form of human preproazurocidin lacking the amino-terminal
heptapropeptide, In conclusion, this investigation is an important additio
n to our precious studies on related azurophil granule proteins, and provid
es novel information concerning the biosynthesis and distinctive amino-term
inal processing of human azurocidin.